Pregnancy outcomes with a long-acting antiretroviral
In a cautiously optimistic report, researchers described pregnancy outcomes in 25 women living with HIV in clinical trials of a new long-acting injectable antiretroviral therapy of cabotegravir and rilpivirine (CAB+RPV). Among 10 live births there was a birth defect (congenital ptosis or drooping eyelid), which was not attributed to the test drugs. There were no …
Pregnancy outcomes with a long-acting antiretroviral Read More »